Complement Component 3 expressed by the endometrial ectopic tissue is involved in the endometriotic lesion formation through mast cell activation
暂无分享,去创建一个
G. Ricci | U. Kishore | A. Martorana | B. Belmonte | S. Zorzet | P. Macor | F. Romano | G. Zito | A. Mangogna | V. Borelli | C. Agostinis | A. Balduit | R. Bulla | M. Toffoli
[1] B. Nilsson,et al. Assessment of the Role of C3(H2O) in the Alternative Pathway , 2020, Frontiers in Immunology.
[2] A. Witek,et al. The role of complement components C1q, MBL and C1 inhibitor in pathogenesis of endometriosis , 2018, Archives of Gynecology and Obstetrics.
[3] Anne Mari Roost,et al. High-throughput mRNA sequencing of stromal cells from endometriomas and endometrium. , 2017, Reproduction.
[4] J. Donnez,et al. Targeting mast cells: a new way to treat endometriosis , 2017, Expert opinion on therapeutic targets.
[5] S. Young,et al. Immune-inflammation gene signatures in endometriosis patients. , 2016, Fertility and sterility.
[6] W. Nelen,et al. Selection of Key Recommendations for the 1 Management of Women with Endometriosis by 2 an International Panel of Patients and 3 Professionals , 2016 .
[7] L. Giudice,et al. Update on Biomarkers for the Detection of Endometriosis , 2015, BioMed research international.
[8] G. Zauli,et al. The Combination of N-Acetyl Cysteine, Alpha-Lipoic Acid, and Bromelain Shows High Anti-Inflammatory Properties in Novel In Vivo and In Vitro Models of Endometriosis , 2015, Mediators of inflammation.
[9] Alfonso Baldi,et al. Serum Biomarker for Diagnosis of Endometriosis , 2014, Journal of cellular physiology.
[10] G. Tseng,et al. Complement Pathway Is Frequently Altered in Endometriosis and Endometriosis-Associated Ovarian Cancer , 2014, Clinical Cancer Research.
[11] G. Remuzzi,et al. Overview of Complement Activation and Regulation , 2013, Seminars in nephrology.
[12] Annalisa Capobianco,et al. Endometriosis, a disease of the macrophage , 2013, Front. Immun..
[13] Takashi Takahashi,et al. The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis. , 2012, Fertility and sterility.
[14] P. Viganò,et al. The selective vitamin D receptor agonist, elocalcitol, reduces endometriosis development in a mouse model by inhibiting peritoneal inflammation. , 2012, Human reproduction.
[15] T. Zollner,et al. Mast cells in endometriosis: guilty or innocent bystanders? , 2012, Expert opinion on therapeutic targets.
[16] E. Mohammadi,et al. Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.
[17] J. Fourquet,et al. Single-nucleotide polymorphisms in the lysyl oxidase-like protein 4 and complement component 3 genes are associated with increased risk for endometriosis and endometriosis-associated infertility. , 2011, Fertility and sterility.
[18] C. Becker,et al. Peripheral biomarkers of endometriosis: a systematic review. , 2010, Human reproduction update.
[19] Xiaomei Zhang,et al. Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. , 2008, Molecular human reproduction.
[20] J. Sikora,et al. Levels of complement components iC3b, C3c, C4, and SC5b-9 in peritoneal fluid and serum of infertile women with endometriosis. , 2007, Fertility and sterility.
[21] J. Waitumbi,et al. Hematin Promotes Complement Alternative Pathway-Mediated Deposition of C3 Activation Fragments on Human Erythrocytes: Potential Implications for the Pathogenesis of Anemia in Malaria1 , 2007, The Journal of Immunology.
[22] John D Lambris,et al. The role of complement in inflammatory diseases from behind the scenes into the spotlight. , 2007, The American journal of pathology.
[23] Idhaliz Flores,et al. Molecular profiling of experimental endometriosis identified gene expression patterns in common with human disease. , 2007, Fertility and sterility.
[24] B. Nilsson,et al. Complement and coagulation: strangers or partners in crime? , 2007, Trends in immunology.
[25] A. Fazleabas,et al. Identification of novel genes regulated by chorionic gonadotropin in baboon endometrium during the window of implantation. , 2007, Endocrinology.
[26] C. Chapron,et al. Pain, mast cells, and nerves in peritoneal, ovarian, and deep infiltrating endometriosis. , 2006, Fertility and sterility.
[27] M. Sugamata,et al. Increase of Activated Mast Cells in Human Endometriosis , 2005, American journal of reproductive immunology.
[28] G. Sant,et al. Increased Numbers of Activated Mast Cells in Endometriosis Lesions Positive for Corticotropin‐Releasing Hormone and Urocortin , 2004, American journal of reproductive immunology.
[29] Mitsuaki Suzuki,et al. Localization of Mast Cells in Endometrial Cysts , 2004, American journal of reproductive immunology.
[30] Mitsuaki Suzuki,et al. Role of immunoreactions and mast cells in pathogenesis of human endometriosis-morphologic study and gene expression analysis- , 2003, Human Cell.
[31] T. Falcone,et al. Peritoneal fluid environment in endometriosis. Clinicopathological implications. , 2003, Minerva ginecologica.
[32] A. Agarwal,et al. Prediction of endometriosis with serum and peritoneal fluid markers: a prospective controlled trial. , 2002, Human reproduction.
[33] M. Walport,et al. Complement. Second of two parts. , 2001, The New England journal of medicine.
[34] M. Walport. Complement. First of two parts. , 2001, The New England journal of medicine.
[35] L. Twiggs,et al. Expression of complement regulatory proteins-CD 35, CD 46, CD 55, and CD 59-in benign and malignant endometrial tissue. , 2000, Gynecologic oncology.
[36] P. Viganò,et al. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis. , 1999, Human reproduction.
[37] A. Yajima,et al. Increased Mast Cell Density in Peritoneal Endometriosis Compared with Eutopic Endometrium with Endometriosis , 1998, American journal of reproductive immunology.
[38] Wiklund Ra,et al. First of two parts , 1997 .
[39] M. Canis,et al. Revised American Society for Reproductive Medicine classification of endometriosis: 1996. , 1997, Fertility and sterility.
[40] K. Isaacson,et al. Localization of the expression of complement component 3 in the human endometrium by in situ hybridization. , 1996, The Journal of clinical endocrinology and metabolism.
[41] P. Butko,et al. Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[42] A. Campana,et al. Investigations on the cell type responsible for the endometrial secretion of complement component 3 (C3). , 1994, Human reproduction.
[43] S. Kennedy. Endometriosis , 1992, The Lancet.
[44] C. Lyttle,et al. The effect of estradiol on the production and secretion of complement component 3 by the rat uterus and surgically induced endometriotic tissue. , 1991, Fertility and sterility.
[45] C. Lyttle,et al. Production and secretion of complement component 3 by endometriotic tissue. , 1989, The Journal of clinical endocrinology and metabolism.
[46] J. Collins,et al. Tumor necrosis factor in peritoneal fluid of women undergoing laparoscopic surgery. , 1988, Fertility and sterility.
[47] P. Arquembourg,et al. Endometriosis: can it produce an autoimmune response resulting in infertility? , 1980, Clinical obstetrics and gynecology.
[48] S. Mott. Supervised Study , 1917 .
[49] R. Harrison. The properdin pathway: an “alternative activation pathway” or a “critical amplification loop” for C3 and C5 activation? , 2017, Seminars in Immunopathology.
[50] C. Gil,et al. The intricate role of mast cell proteases and the annexin A1-FPR1 system in abdominal wall endometriosis , 2014, Journal of Molecular Histology.
[51] R. M. Ackay,et al. First of Two Parts , 2013 .
[52] 小林 浩治. The ferroimmunomodulatory role of ectopic endometriotic stromal cells in ovarian endometriosis , 2012 .
[53] A. Mackay-Sim,et al. Validation of the comparative quantification method of real-time PCR analysis and a cautionary tale of housekeeping gene selection , 2008 .
[54] Wolfgang Amadens. The Second of Two Parts , 2003 .
[55] T. Falcone,et al. Peritoneal fluid environment in endometriosis , 2003 .
[56] R. Milano. Endometrial ability to implant in ectopic sites can be prevented by interleukin-12 in a murine model of endometriosis , 1999 .
[57] I. Damjanov,et al. Immunoproteins in the endometrium: clinical correlates of the presence of complement fractions C3 and C4. , 1987, American journal of obstetrics and gynecology.